Showing results (2721-2730 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|December 4, 2025
ABCB1 and ABCC10 polymorphisms predict sensitivity to first- and third-generation EGFR-TKIs in EGFR-mutant NSCLCSanae Toda-Shiraga, Takehiro Uemura, Akihito Kakihara, et al.Investigational New Drugs|December 17, 2024
Efficacy and safety of the combination of envafolimab and lenvatinib in unresectable hepatocellular carcinoma: a single-arm, multicentre, exploratory phase II clinical studyYi Jiang, Ke Su, Han Li, et al.Investigational New Drugs|December 26, 2024
Clinical features, treatment, and outcomes of nivolumab induced psoriasisShaoli Zhao, Wei Sun, Jichun Sun, et al.Investigational New Drugs|February 5, 2025
Clinical features, diagnosis, and treatment of pembrolizumab induced autoimmune encephalitisLi Zou, Xianlin Rao, Xiyue ZhaoInvestigational New Drugs|January 3, 2025
Immunotherapy in thymic epithelial tumors: an attractive dilemmaNahed Damaj, Dany Nassar, Bilal Chamaa, et al.Investigational New Drugs|August 10, 2024
A randomized phase 1 study of safety, tolerability, and pharmacokinetics of MK-1088, a novel dual adenosine receptor antagonist, in healthy adult participantsPranav Gupta, Manash Chatterjee, Yeonil Kim, et al.Investigational New Drugs|August 19, 2024
Broad-spectrum anti-cancer activity of fused human arginase variantsYenisetti Rajendra Prasad, J Anakha, Snehal Sainath Jawalekar, et al.Investigational New Drugs|August 14, 2024
Clinical characteristics, treatment, and outcomes of pembrolizumab-induced uveitisZhaoquan Wu, Wei Sun, Chunjiang WangInvestigational New Drugs|June 25, 2024
Study on the effects of rapamycin and the mTORC1/2 dual inhibitor OSI-027 on the metabolism of colon cancer cells based on UPLC-MS/MS metabolomicsKai Fan, Yueyuan Wang, Jiangyujing Bian, et al.Investigational New Drugs|November 17, 2023
Molecular profiling and prognostic analysis in Chinese cholangiocarcinoma: an observational, retrospective single-center studyChangkun Zhang, Xia You, Qin Zhang, et al.Pageof 372